Loading insider details...
Beta
Latest Form 4 (Jul 27, 2026): Sale of 7,429 IRD shares, $22.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 27, 2026 | Opus Genetics, Inc. (IRD) | Sale | 7,429 | $22.1K |
| Apr 27, 2026 | Opus Genetics, Inc. (IRD) | Sale | 7,470 | $39.1K |
| Jan 27, 2026 | Opus Genetics, Inc. (IRD) | Grant/Award | 400,000 | n/a |
| Oct 24, 2025 | Opus Genetics, Inc. (IRD) | Tax Withholding | 23,795 | $46.4K |
| Nov 25, 2024 | Opus Genetics, Inc. (IRD) | Purchase | 10,000 | $9.8K |
| Nov 12, 2024 | Opus Genetics, Inc. (IRD) | Grant/Award | 332,800 | n/a |
| Jun 21, 2024 | Clearside Biomedical, Inc. (CLSD) | Grant/Award | 45,000 | n/a |
| May 15, 2024 | Clearside Biomedical, Inc. (CLSD) | Purchase | 7,813 | $10.2K |
| Jun 23, 2023 | Clearside Biomedical, Inc. (CLSD) | Grant/Award | 30,000 | n/a |
| Jun 24, 2022 | Clearside Biomedical, Inc. (CLSD) | Grant/Award | 30,000 | n/a |